华润双鹤药业股份有限公司拥有86年光辉历史，总部位于北京，现有24家子公 司， 1.3万名员工，主营业务涵盖新药研发、制剂生产、药品销售、原料药生产及制 药装备等方面，为华润集团大健康领域化药业务平台。

2024年实现营业收入112.1亿元，净利润16.5亿元，综合实力和研发实力排名均 稳居第14位。

公司旗下药品批文2000余个，在产在销产品330余个，深耕慢病、输液、儿 科、肾科、精神/神经、肿瘤、女性健康等领域， 25个产品年销售收入超亿元。发展 中，公司践行“仿制哺育创新，创新驱动未来”的战略思路，研发创新和外延发展 双轮驱动，推进卓越运营走深走实，加快 11个关键技术平台建设，以国企品质保障 服务民生健康，紧跟国家战略导向布局合成生物等战新产业，以双鹤所能服务国家 所需。

未来，公司将秉承“为人民健康服务”的初心，加快推进高质量发展，致力成 为大众信赖的、创新驱动的世界一流制药企业，为大众健康和行业发展作出更大 贡献。

China Resources Double-Crane Pharmaceutical Co., Ltd. has a glorious history of 86 years. As an army pharmaceutical factory, it was born in the Taihang Mountains in 1939 and was known as Lihua Pharmaceutical Factory externally. In 1949, after moving to Beijing with the army, the first state-owned chemical pharmaceutical factory was newly established, which was later renamed Beijing Pharmaceutical Factory, laying the foundation for Beijing's modern chemical pharmaceutical industry. In 1997, high-quality  assets  were  integrated  to  establish  Double-Crane  Pharmaceutical, which was listed on the Shanghai Stock Exchange. Through external expansion, it has become a cross-regional group based in Beijing and radiating across the country.  In  2010,  it joined  China  Resources  Group,  one of the world's top  500 enterprises. In 2012, it was renamed China Resources Double-Crane and is now the chemical pharmaceutical business platform of China Resources Group in the field of healthcare.

地址：北京市朝阳区望京利泽东二路1号
No.1 Lize East Second Road, Wangjing, Chaoyang District, Beijing